Benjamin Hohl - 06 Mar 2026 Form 4 Insider Report for Enliven Therapeutics, Inc. (ELVN)

Role: CHIEF FINANCIAL OFFICER
Signature: /s/ Benjamin Hohl
Issuer symbol: ELVN
Transactions as of: 06 Mar 2026
Net transactions value: -$295,839
Form type: 4
Filing time: 10 Mar 2026, 18:15:22 UTC
Previous filing: 17 Feb 2026
SEC: View on sec.gov

Reporting Owners (1)

Name	Relationship	Address	Signature	Signature date	CIK
Hohl Benjamin	CHIEF FINANCIAL OFFICER	C/O ENLIVEN THERAPEUTICS, INC., 6200 LOOKOUT ROAD, BOULDER	/s/ Benjamin Hohl	10 Mar 2026	0001882764

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	ELVN	Common Stock	Sale	$295,839	-10,000	-16%	$29.58	51,000	06 Mar 2026	Direct	F1, F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	This transaction was executed in multiple trades at prices ranging from $29.43 to $29.7867. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.
F2	Certain of these securities are restricted stock units (RSUs). Each RSU represents a contingent right to receive one share of the Issuer's Common Stock, subject to the applicable vesting schedule and conditions of each RSU.

Content

This transaction was executed in multiple trades at prices ranging from $29.43 to $29.7867. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.

Certain of these securities are restricted stock units (RSUs). Each RSU represents a contingent right to receive one share of the Issuer's Common Stock, subject to the applicable vesting schedule and conditions of each RSU.